Prevalence of extensively drug-resistant tuberculosis among patients with multidrug-resistant tuberculosis: A retrospective hospital-based study

Indian Journal of Medical Research

Volumn 130, Issue 4, 2009, Pages 392-395

  Sharma, Surendra K ^a   George, Ninoo ^a   Kadhiravan, Tamilarasu ^a   Saha, Pradip K ^a   Mishra, Hemant K ^a   Hanif, Mahmud ^b  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^b New Delhi Tuberculosis Centre   (India)

Author keywords

Drug resistance; Extensively drug; India; Multidrug; Resistant tuberculosis (MDR TB); Resistant tuberculosis (XDR TB); Tuberculosis

Indexed keywords

AMIKACIN; AMINOSALICYLIC ACID; CAPREOMYCIN; CIPROFLOXACIN; CLARITHROMYCIN; CLOFAZIMINE; CYCLOSERINE; ETHAMBUTOL; ETHIONAMIDE; ISONIAZID; KANAMYCIN; OFLOXACIN; PYRAZINAMIDE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; SPARFLOXACIN; STREPTOMYCIN; THIOACETAZONE;

ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; FEMALE; HUMAN; INDIA; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANCE; PREVALENCE; TERTIARY HEALTH CARE; TUBERCULOSIS; TUBERCULOSIS CONTROL;

ADULT; ANTITUBERCULAR AGENTS; EXTENSIVELY DRUG-RESISTANT TUBERCULOSIS; FEMALE; HOSPITALS; HUMANS; INDIA; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; TUBERCULOSIS, MULTIDRUG-RESISTANT; YOUNG ADULT;

EID: 71449111986     PISSN: 09715916     EISSN: 09715916     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Anti-tuberculosis drug resistance in the world. Fourth global report. The WHO/IUATLD Global Project on Antituberculosis drug resistance surveillance; World Health Organization, Geneva 2008. WHO/HTM/TB/2008.394: p. 10-12.
2. World Health Organization. Tuberculosis: MDR-TB & XDR-TB. The 2008 Report; Geneva: WHO the Stop TB Department.
3. Mondal R, Jain A. Extensively drug-resistant Mycobacterium tuberculosis, India. Emerg Infect Dis 2007; 13: 1429-31.
4. Jain S, Rodrigues C, Mehta A, Udwadia ZF. High prevalence of XDR-TB from a tertiary care hospital in India. Proceedings of the American Thoracic Society International Conference, May 2007, San Francisco, USA; Abstract A510.
5. Singh S, Sankar MM, Gopinath K. High rate of extensively drug-resistant tuberculosis in Indian AIDS patients. AIDS 2007; 21: 2345-7.
6. NTI Monograph Series I. Manual for establishing and functioning of a tuberculosis culture laboratory. Bangalore: National Tuberculosis Institute; 1983. p.19.
7. Canetti G, Froman S, Grosset J, Hauduroy P, Langerova M, Mahler HT, et al. Mycobacteria: laboratory methods for testing drug sensitivity and resistance. Bull World Health Organ 1963; 29: 565-78.
8. Centers for Disease Control and Prevention (CDC). Notice to readers: revised definition of extensively drug-resistant tuberculosis. MMWR Morb Mortal Wkly Rep 2005; 55: 1176.
9. Thomas A, Ramachandran R, Rehaman F, Jaggarajamma K, Santha T, Selvakumar N, et al. Management of multidrug resistance tuberculosis in the field: Tuberculosis Research Centre experience. Indian J Tuberc 2007: 54: 117-24.
10. Spellman CW, Matty KJ, Weis SE. A survey of drug-resistant Mycobacterium tuberculosis and its relationship to HIV infection. AIDS 1998; 12: 191-5.
11. Asch S, Knowles L, Rai A, Jones BE, Pogoda J, Barnes PF. Relationship of isoniazid resistance to human immunodeficiency virus infection in patients with tuberculosis. Am J Respir Crit Care Med 1996; 153: 1708-10.
12. Mitnick C, Shin S, Seung KJ, Rich ML, Atwood SS, Furin J, et al. Comprehensive treatment of extensively drug-resistant tuberculosis. N Engl J Med 2008; 359: 563-74.
13. Edlin BR, Tokars JI, Grieco MH, Crawford JT, Williams J, Sordillo EM, et al. An outbreak of multidrug-resistant tuberculosis among hospitalized patients with the acquired immunodeficiency syndrome. N Engl J Med 1992; 326:1514-21.
14. Gandhi NR, Moll A, Sturm AW, Pawinski R, Govender T, Lalloo U, et al. Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa. Lancet 2006; 368: 1575-80.
15. Deivanayagam CN, Rajasekaran S, Venkatesan R, Mahilmaran A, Ahmed PR, Annadurai S, et al. Prevalence of acquired MDR-TB and HIV co-infection. Indian J Chest Dis Allied Sci 2002; 44: 237-42.